NEWS - Bournemouth, UK – June 2015: Solentim are celebrating our 5th anniversary this month. The company was funded and founded in the UK in 2010 by an experienced management team who combine years of experience in the development and commercialization of products and solutions for cell biology workflows.
“During this time Solentim has gone from strength to strength, rapidly establishing a reputation as one of the premier instrument providers in the cell line development sector for biologicals. Our customers recognise us for continuous product innovation in this field which in turn is helping them to meet regulatory requirements for clinical development and shorten their timelines,” commented Aaron Figg, one of the founding Directors of Solentim.
Mr Figg continued “In the last 5 years, in the midst of the most challenging economic climate, one of our core values has been to deliver the highest product quality and customer support. The dedication and commitment of our whole team culminated in our ISO 9001:2008 Quality Management System (QMS) accreditation success earlier this year. Today, we are also somewhat unique, certainly within the UK, for carrying out all of our own original product design, development, manufacturing and international distribution of life science instrumentation. This has resulted in our latest move to a bigger factory, our fourth move in five years, and the opening of a US office”.
Sales and Marketing Director, Dr Ian Taylor, added, “With the Cell Metric™ family, our first commercial product launched 3 years ago, we have become the ‘go-to’ company for proof of clonality in global cell line development for biologics. We have established a diverse geographical installed base through direct sales channels in UK and Europe, and specialist distributors across Asia. Revenues continue to grow year on year, market share is increasing and we are witnessing a general expansion of market size through biosimilars in emerging markets. As our 5th anniversary celebrates exciting and noteworthy business growth for Solentim, we look forward to continued success with the launch of additional new products in 2016.”
------- ENDS -------
Commercial cell line development for biopharmaceutical production is a high value process which is intrinsically expensive and takes a significant amount of time. Solentim is dedicated to the development of innovative tools to shorten steps in the upstream cell line development workflow. The Cell Metric™ product range consists of bio-analytical imaging stations for rapid clone screening and documented proof of monoclonality for the FDA and other regulatory bodies. To find more information visit www.solentim.com
Dr Ian Taylor
E: [email protected]